20102020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

2020

Chemotherapy and Tyrosine Kinase Inhibitors in the last month of life in patients with metastatic lung cancer: A patient file study in the Netherlands

Mieras, A., Becker-Commissaris, A., Pasman, H. R. W., Dingemans, A-M. M. C., Kok, E., Cornelissen, R., Jacobs, W., van den Berg, J. W., Welling, A., Bogaarts, B. A. H. A., Pronk, L. & Onwuteaka-Philipsen, B. D., Mar 2020, In : European Journal of Cancer Care. 29, 2, 10 p., 13210.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Health-related quality of life after prophylactic cranial irradiation for stage III non-small cell lung cancer patients: Results from the NVALT-11/DLCRG-02 phase III study

Witlox, W. J. A., Ramaekers, B. L. T., Joore, M. A., Dingemans, A. -M. C., Praag, J., Belderbos, J., Tissing-Tan, C., Herder, G., Haitjema, T., Ubbels, J. F., Lagerwaard, J., El Sharouni, S. Y., Stigt, J. A., Smitm, E. F., van Tinteren, H., van der Noort, V., Groen, H. J. M. & De Ruysscher, D. K. M., Mar 2020, In : Radiotherapy and Oncology. 144, p. 65-71 7 p.

Research output: Contribution to journalArticleAcademicpeer-review

Identification of microRNAs in skeletal muscle associated with lung cancer cachexia

van de Worp, W. R. P. H., Schols, A. M. W. J., Dingemans, A-M. C., Op den Kamp, C. M. H., Degens, J. H. R. J., Kelders, M. C. J. M., Coort, S., Woodruff, H. C., Kratassiouk, G., Harel-Bellan, A., Theys, J., van Helvoort, A. & Langen, R. C. J., Apr 2020, In : Journal of cachexia, sarcopenia and muscle. 11, 2, p. 452-463 12 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Immunotherapy for nonsmall cell lung cancer: a new therapeutic algorithm

Berghmans, T., Dingemans, A-M., Hendriks, L. E. L. & Cadranel, J., 1 Feb 2020, In : European Respiratory Journal. 55, 2, 5 p., 1901907.

Research output: Contribution to journalEditorialAcademicpeer-review

Oligometastatic non-small cell lung cancer (NSCLC): Does number of metastasis matter?

Giaj-Levra, N., Levra, M. G., Berghmans, T., Novello, S., Hendriks, L. E., Levy, A., Besse, B. & Dingemans, A-M. C., Jan 2020, In : Lung Cancer. 139, p. 216-218 3 p.

Research output: Contribution to journalEditorialAcademicpeer-review

Programmed death-ligand 1 expression influenced by tissue sample size. Scoring based on tissue microarrays' and cross-validation with resections, in patients with, stage I-III, non-small cell lung carcinoma of the European Thoracic Oncology Platform Lungscape cohort

Thunnissen, E., Kerr, K. M., Dafni, U., Bubendorf, L., Finn, S. P., Soltermann, A., Biernat, W., Cheney, R., Verbeken, E., Warth, A., Marchetti, A., Speel, E-J. M., Pokharel, S., Quinn, A. M., Monkhorst, K., Navarro, A., Madsen, L. B., Tsourti, Z., Geiger, T., Kammler, R. & 5 others, Peters, S., Stahel, R. A., European Thoracic Oncology Platform Lungscape Consortium, Dingemans, A-M. & Ruland, A. M., May 2020, In : Modern Pathology. 33, 5, p. 792-801 10 p.

Research output: Contribution to journalArticleAcademicpeer-review

Stereotactic ablative body radiotherapy (SABR) combined with immunotherapy (L19-IL2) versus standard of care in stage IV NSCLC patients, ImmunoSABR: a multicentre, randomised controlled open-label phase II trial

Lieverse, R. I. Y., Van Limbergen, E. J., Oberije, C. J. G., Troost, E. G. C., Hadrup, S. R., Dingemans, A-M. C., Hendriks, L. E. L., Eckert, F., Hiley, C., Dooms, C., Lievens, Y., de Jong, M. C., Bussink, J., Geets, X., Valentini, V., Elia, G., Neri, D., Billiet, C., Abdollahi, A., Pasquier, D. & 5 others, Boisselier, P., Yaromina, A., De Ruysscher, D., Dubois, L. J. & Lambin, P., 15 Jun 2020, In : BMC Cancer. 20, 1, 10 p., 557.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Unique Metastatic Patterns in Neuroendocrine Neoplasms of Different Primary Origin

Hermans, B., Derks, J., Willems, A., Bilochvostenko, M., Bayazit, S., Speel, E. J., Dercksen, W., de Vos-Geelen, J. & Dingemans, A. M., Mar 2020, In : Neuroendocrinology. 110, p. 81-81 1 p.

Research output: Contribution to journalConference Abstract/Poster in journalAcademic

Validation of an analytical method using HPLC-MS/MS to quantify osimertinib in human plasma and supplementary stability results

van Veelen, A., van Geel, R., de Beer, Y., Dingemans, A-M., Stolk, L., Ter Heine, R., de Vries, F. & Croes, S., Apr 2020, In : Biomedical Chromatography. 34, 4, 9 p., e4771.

Research output: Contribution to journalArticleAcademicpeer-review

2019

ALK immunohistochemistry positive, FISH negative NSCLC is infrequent, but associated with impaired survival following treatment with crizotinib

Thunnissen, E., Lissenberg-Witte, B., van den Heuvel, M. M., Monkhorst, K., Skov, B. G., Sorensen, J. B., Mellemgaard, A., Dingemans, A. M. C., Speel, E. J. M., de Langen, A. J., Hashemi, S. M. S., Bahce, I., van der Drift, M. A., Looijen-Salamon, M. G., Gosney, J., Postmus, P. E., Samii, S. M. S., Duplaquet, F., Weynand, B., Durando, X. & 15 others, Penault-Llorca, F., Finn, S., Grady, A. O., Oz, B., Akyurek, N., Buettner, R., Wolf, J., Bubendorf, L., Duin, S., Marondel, L., Heukamp, L. C., Timens, W., Schuuring, E. M. D., Pauwels, P. & Smit, E. F., Dec 2019, In : Lung Cancer. 138, p. 13-18 6 p.

Research output: Contribution to journalArticleAcademicpeer-review

A retrospective cohort study of PD-L1 prevalence, molecular associations and clinical outcomes in patients with NSCLC: Results from the European Thoracic Oncology Platform (ETOP) Lungscape Project

Kerr, K. M., Thunnissen, E., Dafni, U., Finn, S. P., Bubendorf, L., Soltemiann, A., Verbeken, E., Biernat, W., Warth, A., Marchetti, A., Speel, E-J. M., Pokharel, S., Quinn, A. M., Monlchorst, K., Navarro, A., Madsen, L. B., Radonic, T., Wilson, J., De Luca, G., Gray, S. G. & 31 others, Cheney, R., Savic, S., Martorell, M., Muley, T., Baas, P., Meldgaard, P., Blackhall, F., Dingemans, A-M., Dziadziuszko, R., Vansteenkiste, J., Weder, W., Polydoropoulou, V., Geiger, T., Kammler, R., Peters, S., Stahel, R., Stahel, R. A., Rosell, R., Blackhall, F., Dafni, U., Molina, M. A., Bubendorf, L., Weder, W., Thunnissen, E., Peters, S., Finn, S., Hiltbrunner, A., Smit, E., Dingemans, A-M., Pokharel, S. & Lungscape Consortium, May 2019, In : Lung Cancer. 131, p. 95-103 9 p.

Research output: Contribution to journalArticleAcademicpeer-review

Can radiomics help to predict skeletal muscle response to chemotherapy in stage IV non-small cell lung cancer?

de Jong, E. E. C., Sanders, K. J. C., Deist, T. M., van Elmpt, W., Jochems, A., van Timmeren, J. E., Leijenaar, R. T. H., Degens, J. H. R. J., Schols, A. M. W. J., Dingemans, A. -M. C. & Lambin, P., Oct 2019, In : European Journal of Cancer. 120, p. 107-113 7 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Current management of limited-stage SCLC and CONVERT trial impact: Results of the EORTC Lung Cancer Group survey

Levy, A., Hendriks, L. E. L., Le Pechoux, C., Falk, S., Besse, B., Novello, S., Dingemans, A-M. C., Hasan, B., Reck, M., Berghmans, T., Faivre-Finn, C. & EORTC LCG, Oct 2019, In : Lung Cancer. 136, p. 145-147 3 p.

Research output: Contribution to journalArticleAcademicpeer-review

Defining oligometastatic non-small cell lung cancer: A simulated multidisciplinary expert opinion

Hendriks, L. E. L., Dooms, C., Berghmans, T., Novello, S., Levy, A., De Ruysscher, D., Hasan, B., Levra, M. G., Levra, N. G., Besse, B., Vansteenkiste, J., Dingemans, A-M. C. & European Org Res Treatment Canc, Dec 2019, In : European Journal of Cancer. 123, p. 28-35 8 p.

Research output: Contribution to journalArticleAcademicpeer-review

Defining Synchronous Oligometastatic Non-Small Cell Lung Cancer: A Systematic Review

Giaj-Levra, N., Giaj-Levra, M., Durieux, V., Novello, S., Besse, B., Hasan, B., Hendriks, L. E., Levy, A., Dingemans, A-M. C., Berghmans, T. & European Org Res Treatment Canc-Lu, Dec 2019, In : Journal of Thoracic Oncology. 14, 12, p. 2053-2061 9 p.

Research output: Contribution to journalReview articleAcademicpeer-review

Definition of Synchronous Oligometastatic Non-Small Cell Lung Cancer-A Consensus Report

Dingemans, A-M. C., Hendriks, L. E. L., Berghmans, T., Levy, A., Hasan, B., Faivre-Finn, C., Giaj-Levra, M., Giaj-Levra, N., Girard, N., Greillier, L., Lantuejoul, S., Edwards, J., O'Brien, M., Reck, M., Smit, E. F., Van Schil, P., Postmus, P. E., Ramella, S., Lievens, Y., Gaga, M. & 18 others, Peled, N., Scagliotti, G., Senan, S., Paz-Ares, L., Guckenberger, M., McDonald, F., Ekman, S., Cufer, T., Gietema, H., Infante, M., Dziadziuszko, R., Peters, S., Porta, R. R., Vansteenkiste, J., Dooms, C., de Ruysscher, D., Besse, B. & Novello, S., Dec 2019, In : Journal of Thoracic Oncology. 14, 12, p. 2109-2119 11 p.

Research output: Contribution to journalArticleAcademicpeer-review

DLL3 expression in large cell neuroendocrine carcinoma (LCNEC) and association with molecular subtypes and neuroendocrine profile

Hermans, B. C. M., Derks, J. L., Thunnissen, E., van Suylen, R. J., den Bakker, M. A., Groen, H. J. M., Smit, E. F., Damhuis, R. A., van den Broek, E. C., Ruland, A., Speel, E. J. M., Dingemans, A. M. C. & PALGA Grp, Dec 2019, In : Lung Cancer. 138, p. 102-108 7 p.

Research output: Contribution to journalArticleAcademicpeer-review

EORTC Lung Cancer Group survey on the definition of NSCLC synchronous oligometastatic disease

Levy, A., Hendriks, L. E. L., Berghmans, T., Faivre-Finn, C., GiajLevra, M., GiajLevra, N., Hasan, B., Pochesci, A., Girard, N., Greillier, L., Lantuejoul, S., Edwards, J., O'Brien, M., Reck, M., Besse, B., Novello, S., Dingemans, A-M. C. & EORTC LCG, Nov 2019, In : European Journal of Cancer. 122, p. 109-114 6 p.

Research output: Contribution to journalArticleAcademicpeer-review

Factors determining the effect of prophylactic cranial irradiation (PCI) in patients with stage-III nonsmall cell lung cancer: exploratory subgroup analyses of the NVALT-11/DLCRG-02 phase-III study

Witlox, W. J. A., Ramaekers, B. L. T., Groen, H. J. M., Dingemans, A. M., Praag, J., Belderbos, J., van der Noort, V., van Tinteren, H., Joore, M. A. & De Ruysscher, D. K. M., 3 Oct 2019, In : Acta Oncologica. 58, 10, p. 1528-1531 4 p.

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

Genomics of non-small cell lung cancer (NSCLC): Association between CT-based imaging features and EGFR and K-RAS mutations in 122 patients-An external validation

Rizzo, S., Raimondi, S., de Jong, E. E. C., van Elmpt, W., De Piano, F., Petrella, F., Bagnardi, V., Jochems, A., Bellomi, M., Dingemans, A. M. & Lambin, P., Jan 2019, In : European Journal of Radiology. 110, p. 148-155 8 p.

Research output: Contribution to journalArticleAcademicpeer-review

Guideline adherence of mediastinal staging of non-small cell lung cancer: A multicentre retrospective analysis

Bousema, J. E., van Dorp, M., Hoeijmakers, F., Huijbregts, I. A., Barlo, N. P., Bootsma, G. P., van Boven, W. P., Claessens, N. J. M., Dingemans, A-M. C., Hanselaar, W. E., Kortekaas, R. T. J., Lardenoije, J-W. H. P., Maessen, J. G., Schreurs, W. H., Vissers, Y., Youssef-El Soud, M., Dijkgraaf, M. G. W., Annema, J. T. & van den Broek, F. J. C., Aug 2019, In : Lung Cancer. 134, p. 52-58 7 p.

Research output: Contribution to journalArticleAcademicpeer-review

Immune checkpoint inhibitors in non-small-cell lung cancer: key to long-term survival?

Dingemans, A-M. C. & Hendriks, L. E. L., Apr 2019, In : The Lancet Respiratory medicine. 7, 4, p. 291-292 2 p.

Research output: Contribution to journalEditorialAcademicpeer-review

Individualized accelerated isotoxic concurrent chemo-radiotherapy for stage III non-small cell lung cancer: 5-Year results of a prospective study

De Ruysscher, D., van Baardwijk, A., Wanders, R., Hendriks, L. E., Reymen, B., van Empt, W., Ollers, M. C., Bootsma, G., Pitz, C., van Eijsden, L. & Dingemans, A-M. C., Jun 2019, In : Radiotherapy and Oncology. 135, p. 141-146 6 p.

Research output: Contribution to journalArticleAcademicpeer-review

Induction of Peripheral Effector CD8 T-cell Proliferation by Combination of Paclitaxel, Carboplatin, and Bevacizumab in Non-small Cell Lung Cancer Patients

de Goeje, P. L., Poncin, M., Bezemer, K., Kaijen-Lambers, M. E. H., Groen, H. J. M., Smit, E. F., Dingemans, A-M. C., Kunert, A., Hendriks, R. W. & Aerts, J. G. J. V., 1 Apr 2019, In : Clinical Cancer Research. 25, 7, p. 2219-2227 9 p.

Research output: Contribution to journalArticleAcademicpeer-review

Integrative and comparative genomic analyses identify clinically relevant pulmonary carcinoid groups and unveil the supra-carcinoids

Alcala, N., Leblay, N., Gabriel, A. A. G., Mangiante, L., Hervas, D., Giffon, T., Sertier, A. S., Ferrari, A., Derks, J., Ghantous, A., Delhomme, T. M., Chabrier, A., Cuenin, C., Abedi-Ardekani, B., Boland, A., Olaso, R., Meyer, H., Altmuller, J., Le Calvez-Kelm, F., Durand, G. & 50 others, Voegele, C., Boyault, S., Moonen, L., Lemaitre, N., Lorimier, P., Toffart, A. C., Soltermann, A., Clement, J. H., Saenger, J., Field, J. K., Brevet, M., Blanc-Fournier, C., Galateau-Salle, F., Le Stang, N., Russell, P. A., Wright, G., Sozzi, G., Pastorino, U., Lacomme, S., Vignaud, J. M., Hofman, M., Hofman, P., Brustugun, O. T., Lund-Iversen, M., de Montpreville, V. T., Muscarella, L. A., Graziano, P., Popper, H., Stojsic, J., Deleuze, J. F., Herceg, Z., Viari, A., Nuernberg, P., Pelosi, G., Dingemans, A. M. C., Milione, M., Roz, L., Brcic, L., Volante, M., Papotti, M. G., Caux, C., Sandoval, J., Hernandez-Vargas, H., Brambilla, E., Speel, E. J. M., Girard, N., Lantuejoul, S., McKay, J. D., Foll, M. & Fernandez-Cuesta, L., 20 Aug 2019, In : Nature Communications. 10, p. 1-21 21 p., 3407.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Is In-Hospital Mortality Higher in Patients With Metastatic Lung Cancer Who Received Treatment in the Last Month of Life? A Retrospective Cohort Study

Mieras, A., Pasman, H. R. W., Onwuteaka-Philipsen, B. D., Dingemans, A-M. M. C., Kok, E. V., Cornelissen, R., Jacobs, W., van den Berg, J-W., Welling, A., Bogaarts, B. A. H. A., Pronk, L. & Becker-Commissaris, A., Nov 2019, In : Journal of Pain and Symptom Management. 58, 5, p. 805-811 7 p.

Research output: Contribution to journalArticleAcademicpeer-review

Is it time to incorporate surgery in the treatment of stage IV non-small cell lung cancer?

Hendriks, L. E. L. & Dingemans, A-M. C., Mar 2019, In : Lung Cancer. 129, p. 95-97 3 p.

Research output: Contribution to journalEditorialAcademicpeer-review

Is the sum of positive neuroendocrine immunohistochemical stains useful for diagnosis of large cell neuroendocrine carcinoma (LCNEC) on biopsy specimens?

Derks, J. L., Dingemans, A-M. C., van Suylen, R-J., den Bakker, M. A., Damhuis, R. A. M., van den Broek, E. C., Speel, E-J. & Thunnissen, E., Mar 2019, In : Histopathology. 74, 4, p. 555-566 12 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Large cell neuroendocrine carcinoma with a solitary brain metastasis and low Ki-67: a unique subtype

Hermans, B. C. M., Derks, J. L., Groen, H. J. M., Stigt, J. A., van Suylen, R. J., Hillen, L. M., van den Broek, E. C., Speel, E. J. M. & Dingemans, A-M. C., Dec 2019, In : Endocrine Connections . 8, 12, p. 1600-1606 7 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Orthopedia Homeobox (OTP) in Pulmonary Neuroendocrine Tumors: The Diagnostic Value and Possible Molecular Interactions

Moonen, L., Derks, J., Dingemans, A-M. & Speel, E-J., Oct 2019, In : Cancers. 11, 10, 13 p., 1508.

Research output: Contribution to journalReview articleAcademicpeer-review

Open Access

Outcome of Patients with Non-Small Cell Lung Cancer and Brain Metastases Treated with Checkpoint Inhibitors

Hendriks, L. E. L., Henon, C., Auclin, E., Mezquita, L., Ferrara, R., Audigier-Valette, C., Mazieres, J., Lefebvre, C., Rabeau, A., Le Moulec, S., Cousin, S., Duchemann, B., le Pechoux, C., Botticella, A., Ammari, S., Gazzah, A., Caramella, C., Adam, J., Lechapt, E., Planchard, D. & 3 others, De Ruysscher, D., Dingemans, A-M. & Besse, B., Jul 2019, In : Journal of Thoracic Oncology. 14, 7, p. 1244-1254 11 p.

Research output: Contribution to journalArticleAcademicpeer-review

Pharmacokinetically-guided dosing of pemetrexed in a patient with renal impairment and a patient requiring hemodialysis

de Rouw, N., Croes, S., Posthuma, R., Agterhuis, D. E., Schoenmaekers, J. J. A. O., Derijks, H. J., Burger, D. M., Dingemans, A. M. & ter Heine, R., Apr 2019, In : Lung Cancer. 130, p. 156-158 3 p.

Research output: Contribution to journalArticleAcademicpeer-review

Position of an international panel of lung cancer experts on the decision for expansion of approval for pembrolizumab in advanced non-small-cell lung cancer with a PD-L1 expression level of >= 1% by the USA Food and Drug Administration

Mountzios, G., Remon, J., Novello, S., Blais, N., Califano, R., Cufer, T., Dingemans, A. M., Liu, S. V., Peled, N., Pennell, N. A., Reck, M., Rolfo, C., Tan, D., Vansteenkiste, J., West, H. & Besse, B., Nov 2019, In : Annals of Oncology. 30, 11, p. 1686-1688 3 p.

Research output: Contribution to journalEditorialAcademicpeer-review

Prevalence and prognostic value of PD-L1 expression in molecular subtypes of metastatic large cell neuroendocrine carcinoma (LCNEC)

Hermans, B. C. M., Derks, J. L., Thunnissen, E., van Suylen, R. J., den Bakker, M. A., Groen, H. J. M., Smit, E. F., Damhuis, R. A., van den Broek, E. C., Stallinga, C. M., Roemen, G. M., Speel, E. J. M., Dingemans, A. -M. C. & PALGA Grp, Apr 2019, In : Lung Cancer. 130, p. 179-186 8 p.

Research output: Contribution to journalArticleAcademicpeer-review

Randomised phase 3 study of adjuvant chemotherapy with or without nadroparin in patients with completely resected non-small-cell lung cancer: the NVALT-8 study

Groen, H. J. M., van der Heijden, E. H. F. M., Klinkenberg, T. J., Biesma, B., Aerts, J., Verhagen, A., Kloosterziel, C., Pieterman, R., van den Borne, B., Smit, H. J. M., Hoekstra, O., Schramel, F. M. N. H., van der Noort, V., van Tinteren, H., Smit, E. F., Dingemans, A-M. C. & NVALT Study Grp, 27 Aug 2019, In : British Journal of Cancer. 121, 5, p. 372-377 6 p.

Research output: Contribution to journalArticleAcademicpeer-review

Safety and Efficacy of Crizotinib in Patients With Advanced or Metastatic ROS1-Rearranged Lung Cancer (EUCROSS): A European Phase II Clinical Trial

Michels, S., Massuti, B., Schildhaus, H-U., Franklin, J., Sebastian, M., Felip, E., Grohe, C., Rodriguez-Abreu, D., Abdulla, D. S. Y., Bischoff, H., Brandts, C., Carcereny, E., Corral, J., Dingemans, A-M. C., Pereira, E., Fassunke, J., Fischer, R. N., Gardizi, M., Heukamp, L., Insa, A. & 19 others, Kron, A., Menon, R., Persigehl, T., Reck, M., Riedel, R., Rothschild, S. I., Scheel, A. H., Scheffler, M., Schmalz, P., Smit, E. F., Limburg, M., Provencio, M., Karachaliou, N., Merkelbach-Bruse, S., Hellmich, M., Nogova, L., Buettner, R., Rosell, R. & Wolf, J., Jul 2019, In : Journal of Thoracic Oncology. 14, 7, p. 1266-1276 11 p.

Research output: Contribution to journalArticleAcademicpeer-review

Screening for brain metastases in patients with stage III non-small-cell lung cancer, magnetic resonance imaging or computed tomography? A prospective study

Schoenmaekers, J., Hofman, P., Bootsma, G., Westenend, M., de Booij, M., Schreurs, W., Houben, R., De Ruysscher, D., Dingemans, A-M. & Hendriks, L. E. L., Jul 2019, In : European Journal of Cancer. 115, p. 88-96 9 p.

Research output: Contribution to journalArticleAcademicpeer-review

Survival of patients with non-small cell lung cancer having leptomeningeal metastases treated with immune checkpoint inhibitors

Hendriks, L. E. L., Bootsma, G., Mourlanette, J., Henon, C., Mezquita, L., Ferrara, R., Audigier-Valette, C., Mazieres, J., Lefebvre, C., Duchemann, B., Cousin, S., le Pechoux, C., Botticella, A., De Ruysscher, D., Dingemans, A-M. C. & Besse, B., Jul 2019, In : European Journal of Cancer. 116, p. 182-189 8 p.

Research output: Contribution to journalArticleAcademicpeer-review

The prognostic value of early onset, CT derived loss of muscle and adipose tissue during chemotherapy in metastatic non-small cell lung cancer

Degens, J. H. R. J., Sanders, K. J. C., de Jong, E. E. C., Groen, H. J. M., Smit, E. F., Aerts, J. G., Schols, A. M. W. J. & Dingemans, A-M. C., Jul 2019, In : Lung Cancer. 133, p. 130-135 6 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access
2018

Administration of crizotinib via jejunostomy tube: A case report

Knapen, L., Dingemans, A-M. & Croes, S., 2018, In : OA Journal of Clinical Case Reports. 1, 3 p., 005.

Research output: Contribution to journalArticleAcademic

Open Access

A phase I study of nintedanib combined with cisplatin/gemcitabine as first-line therapy for advanced squamous non-small cell lung cancer (LUME-Lung 3)

Forster, M., Hackshaw, A., De Pas, T., Cobo, M., Garrido, P., Summers, Y., Dingemans, A-M. C., Flynn, M., Schnell, D., von Wangenheim, U., Loembe, A-B., Kaiser, R. & Lee, S. M., 1 Jun 2018, In : Lung Cancer. 120, p. 27-33 7 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Applicability of a prognostic CT-based radiomic signature model trained on stage I-III non-small cell lung cancer in stage IV non-small cell lung cancer

de Jong, E. E. C., van Elmpt, W., Rizzo, S., Colarieti, A., Spitaleri, G., Leijenaar, R. T. H., Jochems, A., Hendriks, L. E. L., Troost, E. G. C., Reymen, B., Dingemans, A-M. C. & Lambin, P., Oct 2018, In : Lung Cancer. 124, p. 6-11 6 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Association of molecular status and metastatic organs at diagnosis in patients with stage IV non-squamous non-small cell lung cancer

Kuijpers, C. C. H. J., Hendriks, L. E. L., Derks, J. L., Dingemans, A-M. C., van Lindert, A. S. R., van den Heuvel, M. M., Damhuis, R. A. & Willems, S. M., 1 Jul 2018, In : Lung Cancer. 121, p. 76-81 6 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC

Socinski, M. A., Jotte, R. M., Cappuzzo, F., Orlandi, F., Stroyakovskiy, D., Nogami, N., Rodriguez-Abreu, D., Moro-Sibilot, D., Thomas, C. A., Barlesi, F., Finley, G., Kelsch, C., Lee, A., Coleman, S., Deng, Y., Shen, Y., Kowanetz, M., Lopez-Chavez, A., Sandler, A., Reck, M. & 2 others, IMpower150 Study Grp & Dingemans, A-M., 14 Jun 2018, In : New England Journal of Medicine. 378, 24, p. 2288-2301 14 p.

Research output: Contribution to journalArticleAcademicpeer-review

Brain imaging in early stage non-small cell lung cancer: still a controversial topic?

Schoenmaekers, J. J. A. O., Dingemans, A-M. C. & Hendriks, L. E. L., 1 Jul 2018, In : Journal of Thoracic Disease. 10, p. S2168-S2171 4 p.

Research output: Contribution to journalEditorialAcademicpeer-review

Cumulative incidence rates for CNS and non-CNS progression in two phase II studies of alectinib in ALK-positive NSCLC

Gadgeel, S., Shaw, A. T., Barlesi, F., Crino, L., Yang, J. C-H., Dingemans, A-M. C., Kim, D-W., de Marinis, F., Schulz, M., Liu, S., Gupta, R., Kotb, A. & Ou, S-H. I., 9 Jan 2018, In : British Journal of Cancer. 118, 1, p. 38-42 5 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Current perspective: Osimertinib-induced QT prolongation: new drugs with new side-effects need careful patient monitoring

Schiefer, M., Hendriks, L. E. L., Dinh, D., Lalji, U. & Dingemans, A-M. C., 1 Mar 2018, In : European Journal of Cancer. 91, p. 92-98 7 p.

Research output: Contribution to journalArticleAcademicpeer-review